BioMerieux Recalls ETEST Ceftazidime Strips Due to Stability Issues
BioMerieux SA is recalling ETEST Ceftazidime TZ256 strips because their shelf-life claims are not supported by internal testing.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the hazard is a stability/shelf-life issue without reported injuries or illnesses, fitting the criteria for a moderate severity precautionary recall.
Plain-English summary
BioMerieux SA is recalling ETEST Ceftazidime TZ256 Foam packaging strips. The recall is due to product stability issues, specifically that the current shelf-life claims for these products are not supported by internal testing.
The affected products are ETEST Ceftazidime TZ 0.016-256 strips, which are used to determine the antimicrobial susceptibility of various bacteria. The recall includes specific reference numbers 506758 and 506718, along with a list of associated lot numbers. The products were distributed worldwide, including in the United States and numerous foreign countries.
Healthcare facilities and laboratories should stop using the affected ETEST strips and contact BioMerieux SA for further instructions on how to return or dispose of the product.
The recalled product
- Product
- ETEST Ceftazidime TZ256 Foam packaging, Product Name: ETEST Ceftazidime TZ 0.016-256. ETEST is a quantitative technique for determining the antimicrobial susceptibility of Gram-negative and Gram-positive aerobic bacteria such as Enterobacteriaceae, Pseudomonas, Staphylococcus…
- Manufacturer
- BioMerieux SA
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (15)
- Reference no. 506758
- Lot #1003693010
- 003922720
- 003945330
- 004193850
- 004325620
- 004427220
- 004510540
- 1004720640 & 1004830190 and Reference no. 506718
- Lot #1003788640
- 1003823960
- 1003945320
- 1004427210
- 1004510360
- 1004719300 &1004830170.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 12 recalled by BioMerieux SA under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 12 products in this recall →Related recalls
Same manufacturer · BioMerieux SA
See all →- HighMYLA Diagnostic System Software Versions Recalled for Risk of False Negatives
FDA (Devices) · 2021-10-20
- HighMYLA Laboratory Software: Potential Test Result Alteration from Software Anomaly
FDA (Devices) · 2021-08-18
- ModerateBioMerieux NucliSENS Magnetic Extraction Reagents Recalled Due to Temperature Exposure
FDA (Devices) · 2018-10-31
- ModerateBioMerieux Recalls VIDAS FSH Assay Kits Due to Calibration Issues
FDA (Devices) · 2018-07-04
- ModerateBioMérieux Recalls VITEK 2 Gram Positive Susceptibility Cards Due to Temperature Excursion
FDA (Devices) · 2018-06-20
Same hazard · stability
See all →- ModeratePhilips DigitalDiagnost C90 delivered without required wall stand seismic kit
FDA (Devices) · 2026-06-17
- ModerateAlbuterol inhalers recalled after failing stability specification for particle size distribution
FDA (Drugs) · 2025-08-27
- ModerateHemoCue glucose microcuvettes experienced transit time outside of specified limits
FDA (Devices) · 2025-07-09
- ModerateApollo Care Recalls Vancomycin IV Bags Due to Unsupported Expiry Date
FDA (Drugs) · 2018-04-04
- SevereApollo Care Recalls Vancomycin IV Bags Due to Unsupported Expiry Date
FDA (Drugs) · 2018-03-14
Similar recalls
- ModerateBioMerieux ETEST XM256 Cefuroxime Recalled for Potential Performance Issues
FDA (Devices) · 2017-03-01
- ModerateBioMerieux Recalls Ceftriaxone ETEST Kits Due to Performance Issues
FDA (Devices) · 2017-05-31
- HighBioMerieux Recalls ETEST ETP32 Ertapenem Strips Due to False Results
FDA (Devices) · 2017-05-24
- ModerateETEST Ceftriaxone Antibiotic Test Strips Recalled for Storage Condition
FDA (Devices) · 2023-01-11
- HighBioMerieux Etest Cefotaxime CT 256 In Vitro Diagnostic Recall
FDA (Devices) · 2015-07-08
- LowBiomerieux Recalls Etest Ceftaroline Devices Due to Incorrect Expiration Date
FDA (Devices) · 2014-11-26